Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC)1 and OXB,1 today announce the start of LENTICLAIRTM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, gene ...

Astria Therapeutics, Inc. , a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that it will present three posters at the ...

IntroductionOxidative stress, caused by an imbalance between reactive oxygen species (ROS) and antioxidant defenses, plays a central role in the ...

Union Minister Dr. Jitendra Singh inaugurated today the Pradhan Mantri Swasthya Suraksha Yojana (PMSSY) driven upgraded Super specialty Neurosurgery and Cardiovascular Surgery state-of-the-art ...

Like the war on cancer, the war on Alzheimer’s disease is not going to be won in a single glorious “battle.” Instead, I believe incremental yet transformative progress will ...

Parse Biosciences, the leader in high-throughput single cell sequencing, today announced the launch of Evercode™ WT Penta and Penta 384, the first single cell RNA sequencing kits to profile 5 million ...

GRAND RAPIDS, MI – Experts along Grand Rapids’ Medical Mile are sounding the alarm on the Trump Administration’s proposal to slash “indirect” funding for life-saving research. Michigan earlier this ...

Researchers explored how Pluvicto is used in the community and academic settings and when given by oncologists or urologists.

An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their ...

Pfizer will end global development of its bleeding disorder gene therapy, Beqvez, the Nikkei reported on Thursday.